L-Base
PrivateLast Round
Grant
May 8, 2024
Est. Valuation
$24M
Total Funding Raised
$6.58M
Company Overview
L-Base operates in Healthcare & Life Sciences and is based in Seoul. Its latest recorded funding round was a Grant round in May 2024.
L-Base is a biotechnology company that develops CAGE-derived peptide-based therapeutics designed to overcome resistance to existing anticancer drugs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
L-Base Comparables
Compare L-Base with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ability Pharmaceuticals | 77% | |
| Sprint Bioscience | 74% | |
| Genoscience Pharma | 73% |
For institutional investors. Book with your work email.
L-Base Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 8, 2024 | ||||
| VC Round | Jan 1, 2023 | ||||
| Corporate Funding | Dec 1, 2020 | ||||
| Series A | Jul 20, 2018 | ||||
| Grant | Nov 1, 2016 |
For institutional investors. Book with your work email.
L-Base Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DSC Investment | VC Round |
| Daesung Private Equity | Series A |
| KISED | Grant |
| S&S Investment | VC Round |
| Schmidt | VC Round |
| Korea Development Bank | Series A |
| Government of South Korea | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2023
$804K round led by Daewon Pharmaceutical
- Dec 1, 2020
$1.6M round with participation from Daewon Pharmaceutical.
For institutional investors. Book with your work email.
L-Base Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about L-Base's valuation, stock price, and market status.
Is L-Base a public or private company?
L-Base is a private company.
What is the current stock price of L-Base?
L-Base is a private company, so its shares have no public market price. Caplight tracks L-Base's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is L-Base worth (valuation)?
L-Base's valuation is estimated at $24.0M based on funding round data.
Can I buy L-Base stock?
L-Base shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was L-Base's last funding round?
L-Base's most recent funding round was Grant on May 8, 2024.
Who are the main investors in L-Base?
Key investors in L-Base include DSC Investment, Korea Development Bank.
Will L-Base IPO soon?
No public IPO plans have been announced for L-Base.
How can I track L-Base secondary market activity?
Caplight tracks bids, offers, and trades in L-Base's shares on secondary markets.